Consistent with its role of WEE1i in cell fate and cisplatin resistance probably, a higher levels of wee1 correlate with a poor relapse-free survival stratified from a large public clinical microarray database of ovarian cancer patients undergone chemotherapy, which contained cisplatin, as well as breast tumor patients undergone chemotherapy (Fig. 7d,e)36, 37. This evidence concerns the gene WEE1 and breast neoplasm.